Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Migraine and beta blocker. An overview].

V Pfaffenrath, W Pöllmann, G Kufner

    Fortschritte Der Neurologie-Psychiatrie
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial.

    Cephalalgia : an international journal of headache·2012
    Same author

    Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2012
    Same author

    Force-pain relationship in functional magnetic and electrical stimulation of subjects with paresis and preserved sensation.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2010
    Same author

    Prevalence of chronic migraine and medication overuse headache in Germany--the German DMKG headache study.

    Cephalalgia : an international journal of headache·2009
    Same author

    Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.

    Neurology·2008
    Same author

    [Differential diagnosis of headache].

    MMW Fortschritte der Medizin·2008
    Same journal

    [Rare hereditary and acquired diseases with parkinson's syndrome].

    Fortschritte der Neurologie-Psychiatrie·2026
    Same journal

    [Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].

    Fortschritte der Neurologie-Psychiatrie·2026
    Same journal

    [Dementia with Lewy bodies].

    Fortschritte der Neurologie-Psychiatrie·2026
    Same journal

    [Impact of the PEPP reimbursement system and other developments on inpatient care of general psychiatry patients 2005 to 2022: a retrospective analysis].

    Fortschritte der Neurologie-Psychiatrie·2026
    Same journal

    [The pathology of the brain eating amoeba Naegleria fowleri].

    Fortschritte der Neurologie-Psychiatrie·2026
    Same journal

    [Chronic vestibular syndromes: Correct diagnosis and treatment].

    Fortschritte der Neurologie-Psychiatrie·2026
    See all related articles

    Beta-blockers are common migraine prophylactic drugs. Their effect may stem from stabilizing intrasynaptic serotonin levels in brainstem serotonergic neurons, rather than solely reducing sympathetic tonus.

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Migraine is a common headache syndrome, primarily considered neurogenic.
    • Beta-blockers are frequently prescribed for migraine prophylaxis.
    • Evidence suggests the presence of central beta-receptors influencing migraine pathology.

    Purpose of the Study:

    • To explore the mechanism of action for beta-blockers in migraine treatment.
    • To investigate the potential role of central beta-receptors and serotonin pathways.

    Main Methods:

    • Review of existing evidence on beta-blocker mechanisms.
    • Analysis of beta-blocker properties (intrinsic activity, selectivity, lipophilicity, etc.).
    • Consideration of neurogenic and vascular theories of migraine.

    Main Results:

    Related Experiment Videos

    • Beta-blockers exhibit varied pharmacological properties.
    • The effect of beta-blockers is traditionally attributed to reduced sympathetic tonus and vascular influence.
    • An alternative hypothesis suggests a role in stabilizing intrasynaptic serotonin levels.

    Conclusions:

    • Beta-blockers may exert their prophylactic effect in migraine by stabilizing intrasynaptic serotonin levels.
    • This stabilization is proposed to occur within the serotonergic neurons of the brainstem.